RESPIRATORY CARE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America remains the dominant region in the global respiratory care market and is anticipated to hold 43.1% of the market share in 2024. The primary reason behind North America's dominance in the respiratory care market is the widespread prevalence of chronic respiratory diseases like COPD and asthma. With a continuously aging population in the U.S. and Canada, the requirement for respiratory care equipment will sustain high demand in the coming years. Another important factor contributing to North America's market supremacy is the presence of major players like Philips, ResMed, and BD. These global giants have made significant investments in R&D and manufacturing facilities, giving them an edge over other regional markets. Moreover, reimbursement policies for respiratory therapies are well-defined in the region, making treatments readily accessible and affordable for patients.

The Asia Pacific region exhibits immense growth potential for respiratory care devices. Factors like improving access to healthcare and expanding medical infrastructure are fueling the market growth in developing nations. Rapid urbanization and rising air pollution levels have augmented the incidence of respiratory illnesses among the population. Countries like India, China, and Japan account for a sizeable share of the global COPD and asthma burden. This represents a substantial customer base for manufacturers. At the same time, low production costs are encouraging global players to establish localized manufacturing plants in the region. This allows companies to cater to the demands of the price-sensitive Asian market more efficiently. With growing medical expenditures and increasing policy support, the respiratory care market is projected to record strong gains throughout the forecast period.